Patent EP0353565A1 successfully refreshed from Google Patents.
EP0353565A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Immunostimulating peptides, a process for their preparation and pharmaceutical commpositions containing them
Assignee: Ellem Industria Farmaceutica SpA
•
Filing: 1989-07-21
•
Granted: —
•
Expires: 2009-07-21
Abstract
Abstract The peptides of formula I A-x-Lys-y-B I in which: A is H, a tripeptide of formula Arg-Ala-Arg or an hexapeptide of formula Glu-Lys-Arg-Arg-Ala-Arg x and y, different one from the other, are an arginine (Arg) or a glutamic acid (Glu) residue; B is OH or a tripeptide Arg-Ala-Arg with the proviso that when A is hydrogen and x is Arg, B is different from OH comprising the steps of: a) binding the Boc-protected carboxyterminal aminoacid to a suitable resin; b) reacting the other Boc-protected aminoacids with the resin-bound carboxyterminal aminoacid in the desired sequence; c) removing the protecting groups and releasing the so obtained peptides from the resin, have valuable pharmacological properties as immunostimulating agents.
Inventors
- 👤 Brunetto Brunetti
- 👤 Marco Prada
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-09 03:49
CPC Classifications
C; C07; C07K; C07K7/00; C07K7/04; C07K7/06; A; A61; A61P; A61P37/00; A61P37/02; A61P37/04; C07K14/00; C07K14/435; C07K14/575; C07K14/66; C07K14/662; C07K5/00; C07K5/04; C07K5/08; C07K5/0819; A61K; A61K38/00; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
67 words
Peptides of formula I in which: A is H, a tripeptide of formula Arg-Ala-Arg or an hexapeptide of formula Glu-Lys-Arg-Arg-Ala-Arg x and y, different one from the other, are an arginine (Arg) or a glutamic acid (Glu) residue; B is OH or a tripeptide Arg-Ala-Arg with the proviso that when A is hydrogen and x is Arg, B is different from OH and pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim
67 words
Peptides of formula I in which: A is H, a tripeptide of formula Arg-Ala-Arg or an hexapeptide of formula Glu-Lys-Arg-Arg-Ala-Arg x and y, different one from the other, are an arginine (Arg) or a glutamic acid (Glu) residue; B is OH or a tripeptide Arg-Ala-Arg with the proviso that when A is hydrogen and x is Arg, B is different from OH and pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim
15 words
Peptides of formula I wherein the aminoacids are of the D-, L- or DL series.
Claim 4
Dependent Claim
15 words
Peptides of formula I wherein the aminoacids are of the D-, L- or DL series.
Claim 5
Dependent Claim
10 words
Acetate, trifluorocacetate, sulfate, hydrochloride salts of peptides of formula I.
Claim 6
Dependent Claim
10 words
Acetate, trifluorocacetate, sulfate, hydrochloride salts of peptides of formula I.
Claim 7
Dependent Claim
23 words
A peptide according to claim 1 or 2 selected in the group consisting of Arg-Lys-Glu-Arg-Ala-Arg, Arg-Lys-Glu-Arg-D-Ala-Arg, Arg-Ala-Arg-Arg-Lys-Glu, Arg-D-Ala-Arg-Arg-Lys-Glu, Arg-Ala-Arg-Arg-Lys-Glu-Arg-Ala-Arg, Glu-Lys-Arg, Arg-Ala-Arg-Glu-Lys-Arg, Glu-Lys-Arg-Arg-Ala-Arg, Glu-Lys-Arg-Arg-Ala-Arg-Glu-Lys-Arg.
Claim 8
Dependent Claim
22 words
A pharmaceutical composition having immunostimulating activity comprising as the active principle a peptide of claims 1-4 in admixture with an acceptable carrier.
Claim 9
Dependent Claim
24 words
Use of the peptides of claims 1-4 for the preparation of medicaments having immunostimulating activity for the treatment of primary and secondary immunode ficiencies.
Claim 10
Dependent Claim
12 words
A process for the preparation of peptides of formula I in which:
Claim 11
Dependent Claim
12 words
A process for the preparation of peptides of formula I in which:
Claim 12
Dependent Claim
107 words
A is H, a tripeptide of formula Arg-Ala-Arg or an hexapeptide of formula Glu-Lys-Arg-Arg-Ala-Arg x and y, different one from the other, are an arginine (Arg) or a glutamic acid (Glu) residue; B is OH or a tripeptide Arg-Ala-Arg with the proviso that when A is hydrogen and x is Arg, B is different from OH comprising the steps of: a) binding the Boc-protected carboxyterminal aminoacid to a suitable resin; b) reacting the other Boc-protected aminoacids with the resin-bound carboxyterminal aminoacid in the desired sequence; c) removing the protecting groups and releasing the so obtained peptides from the resin. Claims for the following Contracting States: ES, GR
Claim 13
Dependent Claim
111 words
A process for the preparation of peptides of formula I in which: A is H, a tripeptide of formula Arg-Ala-Arg or an hexapeptide of formula Glu-Lys-Arg-Arg-Ala-Arg x and y, different one from the other, are an arginine (Arg) or a glutamic acid (Glu) residue; B is OH or a tripeptide Arg-Ala-Arg with the proviso that when. A is hydrogen and x is Arg, B is different from OH comprising the steps of: a) binding the Boc-protected carboxyterminal aminoacid to a suitable resin; b) reacting the other Boc-protected aminoacids with the resin-bound carboxyterminal aminoacid in the desired sequence; c) removing the protecting groups and releasing the so obtained peptides from the resin.
Claim 14
Dependent Claim
111 words
A process for the preparation of peptides of formula I in which: A is H, a tripeptide of formula Arg-Ala-Arg or an hexapeptide of formula Glu-Lys-Arg-Arg-Ala-Arg x and y, different one from the other, are an arginine (Arg) or a glutamic acid (Glu) residue; B is OH or a tripeptide Arg-Ala-Arg with the proviso that when. A is hydrogen and x is Arg, B is different from OH comprising the steps of: a) binding the Boc-protected carboxyterminal aminoacid to a suitable resin; b) reacting the other Boc-protected aminoacids with the resin-bound carboxyterminal aminoacid in the desired sequence; c) removing the protecting groups and releasing the so obtained peptides from the resin.
References Cited (Backward Citations)
NL7004811A
Cited
WO1983000146A1
Cited
EP0122818A1
Cited
EP0171315A1
Cited
WO1986001210A1
Cited
WO1987002775A1
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.